美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

國藥控股ADR

14.01

+0.04000.29%

成交量：1.57萬

成交額：21.96萬

市值：87.44億

市盈率：8.96

高：14.09

開：14.08

低：13.97

收：13.97

52周最高：14.87

52周最低：10.72

股本：6.24億

流通股本：2.68億

量比：0.46

換手率：0.01%

股息：0.47

股息率：3.36%

每股收益(TTM):1.56

每股收益(LYR):1.55

淨資產收益率：7.83%

總資產收益率：2.54%

市淨率：0.73

市盈率(LYR):9.05

資料載入中...

總覽公司新聞資訊公告

國藥控股與天士力醫藥集團達成戰略合作共築「戰略一體化服務」生態新標杆

啱啱！國藥控股董事長正式官宣

122億！國藥控股大合作來了

中食药信息网

國藥控股（湖南）醫藥創新產業園即將投產

復宏漢霖重續與國藥控股經銷協議年度上限逐年遞增

國藥控股董事長換人！

美國OTC市場國藥控股盤中異動股價大漲5.44%報13.67美元

國藥控股相關公司新增一項122.34萬元的招標項目

國藥控股天和吉林醫藥有限公司中標吉林大學第二醫院激光光學系統採購項目

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SHTDY/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"SHTDY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SHTDY\",,,,,undefined,":{"symbol":"SHTDY","market":"US","secType":"STK","nameCN":"國藥控股ADR","latestPrice":14.01,"timestamp":1772045580000,"preClose":13.97,"halted":0,"volume":15659,"delay":15,"changeRate":0.0028632784538295737,"floatShares":268330371,"shares":624131238,"eps":1.563169,"marketStatus":"交易中","change":0.04,"latestTime":"02-25 13:53:00 EST 延時","open":14.08,"high":14.088,"low":13.97,"amount":219563.373155,"amplitude":0.008447,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":1.563169,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1772053200000},"marketStatusCode":2,"adr":0,"adrRate":5,"exchange":"PINK LIMITED","adjPreClose":13.97,"volumeRatio":0.455087},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SHTDY\",,,,,undefined,":{"symbol":"SHTDY","floatShares":268330371,"roa":"2.54%","roe":"7.83%","lyrEps":1.547539,"volumeRatio":0.455087,"shares":624131238,"dividePrice":0.471279,"high":14.088,"amplitude":0.008447,"preClose":13.97,"low":13.97,"week52Low":10.72,"pbRate":"0.73","psRate":"0.10","week52High":14.87,"institutionHeld":0,"latestPrice":14.01,"eps":1.563169,"divideRate":0.033639,"volume":15659,"delay":15,"ttmEps":1.563169,"open":14.08,"prevYearClose":12.4,"prevWeekClose":13.48,"prevMonthClose":13.3,"prevQuarterClose":12.4,"fiveDayClose":13.72,"twentyDayClose":13.32,"sixtyDayClose":13.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SHTDY\",params:#limit:5,,,undefined,":[{"date":"2025-06-17","symbol":"SHTDY","amount":0.471279,"announcedDate":"2025-05-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-17","defaultRemindTime":1750167000000,"name":"国药控股ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-27","payableDate":"2025-06-17","currency":"USD","dateTimestamp":1750132800000,"payDate":"2025-08-27"},{"market":"US","date":"2024-08-22","symbol":"SHTDY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1724299200000,"reportTimeType":"post","actualEps":null},{"date":"2024-06-18","symbol":"SHTDY","amount":0.6011,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-18","defaultRemindTime":1718717400000,"name":"国药控股ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-08-28","payableDate":"2024-06-18","currency":"USD","dateTimestamp":1718683200000,"payDate":"2024-08-28"},{"market":"US","date":"2024-04-25","symbol":"SHTDY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-03-21","symbol":"SHTDY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1710993600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SHTDY\",market:\"US\",,,undefined,":[{"executeDate":"2016-06-17","recordDate":"2016-06-21","paymentDate":"2016-08-30","value":0.246246,"currency":"USD"},{"executeDate":"2019-07-01","recordDate":"2019-07-02","paymentDate":"2019-09-11","value":0.347513,"currency":"USD"},{"executeDate":"2020-06-12","recordDate":"2020-06-15","paymentDate":"2020-08-26","value":0.333835,"currency":"USD"},{"executeDate":"2021-06-14","recordDate":"2021-06-15","paymentDate":"2021-08-25","value":0.427193,"currency":"USD"},{"executeDate":"2022-06-24","recordDate":"2022-06-27","paymentDate":null,"value":0.480451,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SHTDY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2353,"buy":0.4118,"hold":0.3529,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4118,"analysts":17,"updateTime":1767762000000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SHTDY\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2594266579","title":"國藥控股與天士力醫藥集團達成戰略合作 共築「戰略一體化服務」生態新標杆","url":"https://stock-news.laohu8.com/highlight/detail?id=2594266579","media":"国药控股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594266579?lang=zh_tw&edition=fundamental","pubTime":"2025-12-25 20:50","pubTimestamp":1766667043,"startTime":"0","endTime":"0","summary":"近日，国药控股与天士力医药集团举行战略合作沟通会。国药控股副总裁胡立刚，天士力医药党委书记、董事长周辉出席并见证签约。国药控股所属35家子公司负责人，天士力医药集团团队负责人共同参会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225215126a6cee6e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225215126a6cee6e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SHTDY","BK4175"],"gpt_icon":0},{"id":"2593348927","title":"啱啱！國藥控股董事長正式官宣","url":"https://stock-news.laohu8.com/highlight/detail?id=2593348927","media":"制药在线","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593348927?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 13:39","pubTimestamp":1766381987,"startTime":"0","endTime":"0","summary":"国药控股董事长职位调整尘埃落定。国药控股换帅落定同步更新董事名单12月19日，随着国药控股股东特别大会的召开，国药控股此前提名的国药系老将晋斌正式出任董事长。目前，国药控股最新董事名单已同步更新，具体角色与职能如下：营收承压亟待破局已开启多项合作目前来看，晋斌上任之际，国药控股正面临持续的营收增长压力。强强合作成为国药控股扭转营收颓势的方式之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222133956a6bff438&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222133956a6bff438&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4175","SHTDY"],"gpt_icon":0},{"id":"2589866834","title":"122億！國藥控股大合作來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2589866834","media":"中食药信息网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589866834?lang=zh_tw&edition=fundamental","pubTime":"2025-12-04 21:35","pubTimestamp":1764855320,"startTime":"0","endTime":"0","summary":"免费领取10学时视频课程中食药智慧教育管理平台2025年12月03日，复宏汉霖消息称，将重续与国药控股经销合作，合作期限为2026年1月1日至2028年12月31日。2023年-2025年9月，国药控股分别完成了19.17亿元、20.40亿元以及16.93亿元的销售额。在此背景下，国药控股与复宏汉霖再次达成合作，未来三年的产品销售总额上限高达122.24亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205021829a4cd1d17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205021829a4cd1d17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4175","SHTDY"],"gpt_icon":0},{"id":"2589834850","title":"國藥控股（湖南）醫藥創新產業園即將投產","url":"https://stock-news.laohu8.com/highlight/detail?id=2589834850","media":"红网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589834850?lang=zh_tw&edition=fundamental","pubTime":"2025-12-04 16:49","pubTimestamp":1764838153,"startTime":"0","endTime":"0","summary":"国药控股（湖南）医药创新产业园作为国药控股湖南有限公司布局医药健康供应链的重点项目，国药控股（湖南）医药创新产业园于2024年4月正式开工建设，核心定位为现代化、智慧化医药健康产业供应链枢纽与服务平台，建成后将进一步完善区域医药供应链体系，提升公共卫生应急保障能力。相较于一期项目，国药控股（湖南）医药创新产业园在功能升级、技术应用、服务效能上实现质的飞跃。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204165227a72362b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204165227a72362b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SHTDY","BK4175"],"gpt_icon":0},{"id":"2589983486","title":"復宏漢霖重續與國藥控股經銷協議 年度上限逐年遞增","url":"https://stock-news.laohu8.com/highlight/detail?id=2589983486","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589983486?lang=zh_tw&edition=fundamental","pubTime":"2025-12-04 10:03","pubTimestamp":1764813828,"startTime":"0","endTime":"0","summary":"12月3日，复宏汉霖（02696）发布公告，宣布与国药控股的经销框架协议（2025重续）已达成，该协议的初始期限自2023年1月1日起至2025年12月31日止，现已自动续期三年，新的协议有效期自2026年1月1日至2028年12月31日。根据协议，复宏汉霖将继续向国药控股集团销售其产品，预计在2026年、2027年及2028年，每年的交易金额上限分别为38.7亿元、39.01亿元及44.53亿元。过去的交易金额显示，2023年和2024年期间，复宏汉霖自国药控股收到的销售收入分别约为19.17亿元及20.41亿元，而截至2025年9月30日的九个月内，销售金额约为16.93亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204100744a4cb8520&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204100744a4cb8520&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SHTDY","BK4175"],"gpt_icon":0},{"id":"2588101775","title":"國藥控股董事長換人！","url":"https://stock-news.laohu8.com/highlight/detail?id=2588101775","media":"制药在线","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588101775?lang=zh_tw&edition=fundamental","pubTime":"2025-12-01 11:39","pubTimestamp":1764560346,"startTime":"0","endTime":"0","summary":"国药控股董事长赵炳祥将辞职国药系老将晋斌接棒11月28日，国药控股发布公告，由于工作安排原因，赵炳祥已向董事会提出辞任非执行董事、董事会董事长、董事会提名委员会主席、董事会战略与投资委员会主席、董事会法律合规与环境、社会及治理委员会委员及公司授权代表职务。国药控股的零售业务增速并未形成绝 对优势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512011139169523d4fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512011139169523d4fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4175","SHTDY"],"gpt_icon":0},{"id":"2582375132","title":"美國OTC市場國藥控股盤中異動 股價大漲5.44%報13.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582375132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582375132?lang=zh_tw&edition=fundamental","pubTime":"2025-11-11 23:34","pubTimestamp":1762875294,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日23时34分，美国OTC市场国药控股股票出现异动，股价急速上涨5.44%。美国OTC市场国药控股股票所在的医疗销售行业中，整体跌幅为0.43%。美国OTC市场国药控股公司简介：国药控股股份有限公司成立于2003年，是中国最大的药品和医疗器械批发商和零售商，2009年在香港联交所上市。截至2024年底，国药控股最大的业务部门是药品分销，占其总收入的70%以上。目前，医疗器械分销占国药控股总收入的20%以上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111233454a6f25546&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111233454a6f25546&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SHTDY","BK4175"],"gpt_icon":0},{"id":"2565330742","title":"國藥控股相關公司新增一項122.34萬元的招標項目","url":"https://stock-news.laohu8.com/highlight/detail?id=2565330742","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565330742?lang=zh_tw&edition=fundamental","pubTime":"2025-09-04 23:50","pubTimestamp":1757001000,"startTime":"0","endTime":"0","summary":"（来源：快查一企业中标了）快查APP显示，国药控股相关公司国药控股菱商医院管理服务(上海)有限公司于2025年9月4日发布一则招标信息，项目名称为国药控股菱商医院管理服务(上海)有限公司医院智能管理设备租赁服务项目招标公告，预算金额为122.34万元。快查股权穿透数据显示，该公司由国药控股持股，出资比例为60%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090423572497780183&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090423572497780183&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01099","LU1115378108.SGD","BK1515","BK1500","SHTDY","LU0640798160.USD","BK1197"],"gpt_icon":0},{"id":"2565258078","title":"國藥控股天和吉林醫藥有限公司中標吉林大學第二醫院激光光學系統採購項目","url":"https://stock-news.laohu8.com/highlight/detail?id=2565258078","media":"DoNews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565258078?lang=zh_tw&edition=fundamental","pubTime":"2025-09-04 13:25","pubTimestamp":1756963503,"startTime":"0","endTime":"0","summary":"天眼查App显示，2025年9月3日，吉林大学第二医院激光光学系统采购项目公布中标结果。中标供应商为国药控股天和吉林医药有限公司，中标金额为35万元。采购人吉林大学第二医院位于吉林省长春市，本次采购项目内容为激光光学系统设备的采购。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090413264195128626&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090413264195128626&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SHTDY","BK4175"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}]}}